Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Josep M Llovet
Molecular Predictors of Prevention of Recurrence in HCC With Sorafenib as Adjuvant Treatment and Prognostic Factors in the Phase 3 STORM Trial
Gut
Gastroenterology
Linking Molecular Classification of Hepatocellular Carcinoma and Personalized Medicine: Preliminary Steps
Current Opinion in Oncology
Cancer Research
Oncology
Related publications
Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
Cancer Research and Treatment
Cancer Research
Oncology
Physical Therapy as an Adjuvant Treatment for the Prevention and Treatment of Cancer
Klinicka Onkologie
Oncology
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Sorafenib or Placebo Plus TACE With Doxorubicin-Eluting Beads for Intermediate Stage HCC: The SPACE Trial
Journal of Hepatology
Hepatology
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Evaluation of Prognostic Factors of Local Recurrence in Atypical Meningiomas
Haydarpasa Numune Training and Research Hospital Medical Journal
Changing TACTICS in Intermediate HCC: TACE Plus Sorafenib
Gut
Gastroenterology
Design of RESILIENCE: A Phase 3 Trial Comparing Capecitabine in Combination With Sorafenib or Placebo for Treatment of Locally Advanced or Metastatic HER2-negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
